The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
The Joint Corp.NASDAQ: JYNT
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin grows, but more slowly than its trailing trend
Q1 FY2026 selling, general & admin of $10.8M rose 3.7% year over year, behind the +319.1% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 3.3% from the prior quarter. Over 3 fiscal years it compounded at -19.4% a year.
Context
- Selling, general & admin amounted to 78.2% of revenue in FY2025, down 0.6 pp from a year earlier.
- Selling, general & admin increased in 2 of the last 3 fiscal years.
What to watch
Whether selling, general & admin reaches the consensus estimate from 3 analysts of $45.34M (+5.6%) for the fiscal year ending Dec 2026, a step up from the +4.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $10.8M-3.3% QoQ
- Last fiscal yearDec 2025
- $42.93M+4.5% YoY
- LTMMar 2026
- $43.12M+319.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.7% | +1.3% | -2.4 pp |
| 1 year | +4.5% | +5.6% | +1.2 pp |
| 3-year CAGR | -19.4% | +0.5% | +19.9 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 42.93M USD
- Year-over-year change
- +4.5%
- 4-year CAGR
- -8.9%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.93M | +4.5% |
| FY2024 | 2024-12-31 | 41.1M | +17.7% |
| FY2023 | 2023-12-31 | 34.92M | -57.4% |
| FY2022 | 2022-12-31 | 81.95M | +31.6% |
| FY2021 | 2021-12-31 | 62.27M | — |
Selling, General & Admin vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 selling, general & admin of $43.12M is the 4th highest of the 11 companies compared; the peer median is $28.73M.
- Its year-over-year change of +319.1% is the 3rd highest of 11, against a peer median of +8.8%.
- Selling, general & admin amounts to 76.1% of revenue for JYNT, versus a peer median of 3216.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $31.21T | +20801703.5% | +10.7% | 10343531.1% | |
| LTM Mar 2026 | $20.08B | +51937.5% | +914.5% | 391112.6% | |
| LTM Mar 2026 | $96.82M | -11.5% | -17.8% | 51.5% | |
| LTM Mar 2026 | $43.12M | +319.1% | -19.4% | 76.1% | |
| LTM Mar 2026 | $37.26M | +7.2% | -5.9% | 108.4% | |
| LTM Mar 2026 | $31.78M | -9.7% | -9.1% | 56.8% | |
| LTM Mar 2026 | $25.68M | +75.9% | +56.0% | — | |
| LTM Mar 2026 | $25.1M | +255.8% | +44.6% | 6323.8% | |
| LTM Mar 2026 | $24.65M | +10.4% | -11.6% | 19.9% | |
| LTM Mar 2026 | $23.64M | +5.4% | -9.6% | 41470.2% | |
| LTM Mar 2026 | $10.32M | -12.0% | -7.1% | — | |
| Peer median (excluding JYNT) | $28.73M | +8.8% | -6.5% | 3216.1% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 80.01M | 101.25M | 46.98M | 52.16M | 54.9M |
| Cost of Revenue | 7.67M | 9.17M | 10.48M | 11.52M | 11.23M |
| Gross Profit | 72.35M | 92.08M | 36.5M | 40.65M | 43.67M |
| Gross Margin | 90.4% | 90.9% | 77.7% | 77.9% | 79.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 62.27M | 81.95M | 34.92M | 41.1M | 42.93M |
| Operating Expenses | 66.22M | 91.25M | 36.18M | 42.54M | 44.58M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| EBITDA | 10.07M | 7.89M | 8.88M | 2.9M | 1.48M |
| EBITDA Margin | 12.6% | 7.8% | 18.9% | 5.6% | 2.7% |
| Operating Income | 6.13M | 828.25K | 318.3K | (1.89M) | (905.48K) |
| Operating Margin | 7.7% | 0.8% | 0.7% | -3.6% | -1.6% |
| Interest Income | 0 | 133.1K | 0 | 280.29K | 0 |
| Interest Expense | 0 | 953.53K | 64.29K | 0 | 0 |
| Other Income / Expenses | (69.88K) | (133.1K) | (64.29K) | 280.29K | 675.97K |
| Income Before Tax | 6.06M | 695.15K | 254.01K | (1.61M) | (229.5K) |
| Pre-Tax Margin | 7.6% | 0.7% | 0.5% | -3.1% | -0.4% |
| Income Tax Expense | (1.51M) | 68.45K | 11.02M | 5.61K | 38.65K |
| Net Income | 7.57M | 626.71K | (9.75M) | (5.8M) | 2.91M |
| Net Margin | 9.5% | 0.6% | -20.8% | -11.1% | 5.3% |
| EPS (Basic) | 0.46 | 0.04 | (0.66) | (0.39) | 0.19 |
| EPS (Diluted) | 0.44 | 0.04 | (0.66) | (0.39) | 0.19 |
| Weighted Avg Shares | 14.32M | 14.49M | 14.69M | 14.92M | 15.13M |
| Weighted Avg Shares (Diluted) | 14.94M | 14.87M | 14.69M | 15.15M | 15.13M |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.